Top stocks in focus: Axis Bank, Alembic Pharma, Dr. Reddy’s Laboratories

Check out the companies which will be in focus during trade today based on recent and latest news developments.

Feb 12, 2019 02:02 IST India Infoline News Service

SUUTI to sell up to 3% stake in Axis Bank via OFS; floor price set at Rs689.52/share.

Alembic Pharma’s JV (with Orbicular) received 2 observations from the USFDA inspection at Karakhadi formulation manufacturing facility.

Indivior lost bid to stay mandate in the Dr. Reddy’s Laboratories’ Suboxone Case.

RBI imposes the penalty of Rs1.5cr on Indian Overseas Bank due to non-monitoring of the end use of funds and delays in reporting of fraud in respect of one of its borrowers.

IFCI increased benchmark rates for short term loans by 10 basis points to 9.3%.

Bank of America likely to have bid for part of SBI’s $2.2bn loans to Essar, reports said.

Max Financial Services appoints Analjit Singh as Chairman of Max India and Max Life with effect from April 01.

KNR Constructions to sell entire shareholding in its SPV with Cube Highways and Infra for Rs34.46cr.

Arshiya’s two arms to acquire warehouses in Uttar Pradesh for Rs118cr.

Gulf Oil Lubricants announced an association with Mahindra Logistics for supply chain solutions.

Related Story